Found 6 matching trials
Treatment of Hemophilia A Patients With FVIII Inhibitors N/A This is a non-interventional, multicenter, observational, international stu...
Show More Location
Arthur M. Blank Hospital
Learn More & Join Trial
Trial of NovoSeven® in Haemophilia - Joint Bleeds PHASE4 This trial is conducted in the United States of America (USA). This study c...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII PHASE4 Patients with severe hemophilia and inhibitors can be treated effectively b...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors PHASE3 This multicenter, open-label study will evaluate the safety, efficacy and p...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX N/A This study is conducted in the United States of America (USA). The aim of t...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis PHASE3 The purpose of the aPCC-emicizumab safety study is to investigate the hemos...
Show More Location
Children's Healthcare of Atlanta
Learn More & Join Trial